Accelerating the discovery of a cure for ALS.
Learn about our innovative prize model.

Prize4Life was founded in 2006 with a singular mission: to accelerate the discovery of treatments and a cure for ALS, a terminal disease whose cause has eluded scientists for over a century. Since then, we have successfully launched and awarded several prizes and programs that have taken us closer to fulfilling that mission.

In late 2013, the Board of Directors and management team of Prize4Life made the decision to re-focus its' activities to support a single focus: the $1M Avi Kremer ALS Treatment Prize.  The rest of Prize4Life's scientific programs, including the ALS Gene Database, ALS Research Forum and the award-winning PRO-ACT Database were transferred to its' sister organization, Prize4Life Israel.  

On January 31, 2017, Prize4Life announced that Drs. Martine Barkats and Maria Grazia Biferi from the Institute of Myology in Paris, France had won the $1M Avi Kremer ALS Treatment Prize! To learn more about their winning gene therapy currently in preclinical development, please click here.  The prize was awarded on April 25, 2017 in Boston, Massachusetts in conjunction with an event at the 69th Annual American Academy of Neurology Meeting.

We are currently in the process of defining our next programs and prizes - stay tuned for more information!  For questions about Prize4Life - past, present and future - please contact us at